openPR Logo
Press release

Gene Therapy Market to be Worth over USD 10 billion by 2025, predicts Roots Analysis

09-12-2017 07:58 AM CET | Health & Medicine

Press release from: Roots Analysis

Roots Analysis has announced the addition of “Gene Therapy Market, 2015-2025” report to their offering. The market currently has only five approved therapies; of these, four are commercialised in geographies other than the US and EU. Roots Analysis’ latest research provides in depth insights not only on the approved therapies (Gendicine, Rexin-G, Oncorine, Neovasculgen and Glybera) but also on several other therapies in late stage of development.

Ishita Nanda, the principal analyst, said, “Due to the stringent FDA and EMA regulations, gene therapy has so far made its entry only in the Asian markets; it is yet to be made commercially available in the developed markets. However, with a robust pipeline of close to 500 molecules, the future looks highly promising. Active participation of the venture capital firms is significantly backing up the massive research being carried out for upcoming gene therapies.”

Nanda further stated, “The current approach is likely to result in several commercial success stories in the foreseeable future. Our study covers various aspects, such as key players, marketed gene therapy products, products in clinical / pre-clinical research, likely future developments and upcoming opportunities for a variety of stakeholders. We have identified the development and sales potential based on target consumer segments, likely adoption rate and expected pricing.”

Some of the key insights captured in the 279 page detailed report include:
20% of therapies are in late stage of clinical development; Oncology based gene therapies are the most popular, accounting for 42% of the total pipeline.
Interest from venture capital firms is growing; during January 2013 to April 2014, a total USD 600 million was raised by the US companies alone.
The market, estimated to grow at a CAGR of 48.9% over the coming decade, is likely to be worth USD 11 billion by 2025; specific therapies such as Prostavac, ProstAtak and TroVax are likely to achieve blockbuster status.


Who will benefit from this report?
This research is targeted towards pharma companies and research groups working in the field of gene therapy. In particular, you will benefit if you are an:
Investor
Contract manufacturer
R&D Manager
Business Intelligence / Scientific Analyst
Licensing / Portfolio Manager
Strategy Manager

About Roots Analysis
Roots Analysis is a specialist market research company, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like us to help you with your growing business needs, get in touch at info@rootsanalysis.com

Roots Analysis
For additional details, please visit http://www.rootsanalysis.com/reports/view_document/gene-therapy-market-2015-2025/85.html

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gene Therapy Market to be Worth over USD 10 billion by 2025, predicts Roots Analysis here

News-ID: 709725 • Views: 167

More Releases from Roots Analysis

The contract manufacturing services market for stem cells is expected to be wort …
Roots Analysis has announced the addition of the “Stem Cell Contract Manufacturing Market, 2019-2030” report to its list of offerings. Owing to a highly regulated production environment and the need for state-of-the-art technologies and equipment, it is difficult for innovators to establish in-house expertise for the large-scale manufacturing of stem cell therapies. As a result, stem cell therapy developers are increasingly relying on contract manufacturing organizations (CMOs) for their product
Chronic Kidney Disease Market: Pipeline Review, Developer Landscape and Competit …
Roots Analysis has announced the addition of “Chronic Kidney Disease Market: Pipeline Review, Developer Landscape and Competitive Insights” report to its list of offerings. Ishita Nanda, the principal analyst, stated, “Chronic kidney disease is responsible for approximately 5-10 million deaths per year, worldwide. In fact, over 90% of the patients suffering from reduced kidney function are unaware of their medical condition. The market is therefore, characterized by a pressing need
Real World Evidence: Market Landscape and Competitive Insights, 2018-2030
Roots Analysis has announced the addition of “Real World Evidence: Market Landscape and Competitive Insights, 2018-2030” report to its list of offerings. Prabhjot Kaur, the principal analyst, stated, “Currently, close to 200 industry players are actively involved in providing real world data / analytics / services to the pharmaceutical and life sciences industries. Of these, more than 120 players leverage clinical data (derived from medical and patient care records) and
Smart Wearables: The Future of Personalized Healthcare
Roots Analysis has announced the addition of the “Smart Wearables in Healthcare, 2016-2030” report to its list of offerings. The report provides a comprehensive analysis of the current market landscape with respect to key players and specific applications of the diverse range of products in this sector. It also presents a detailed future outlook and opportunity analysis of the smart wearables market from a healthcare and fitness perspective. Tapish Dogra,

All 5 Releases


More Releases for Manager

Amazon Account Manager
Revanth Infotech is successfully delivery e-commerce solution to many marketplace vendors. They specializes in providing a complete ecosystem for achieving higher sales on Amazon & other E-commerce platforms. It is an one stop solution for setting up, running and growing your business on Amazon & other e-commerce marketplaces without compromising your existing business.By precise strategies, they tailor-out to suit any marketplace business, by analysing competitor data to beat them at
Voyage Manager Goes Messaging
Travellers’ instant messaging statuses can now be automatically updated with their latest Voyage Manager travel status updates. Voyage Manager has move travel tracking to a new level with the integration of the VM Travel Tracking Suite with the Microsoft’s Windows Live Messenger. The instant messenger integration can automatically post travellers’ travel status updates, allowing friends, family and colleagues to easily know the current location of the traveller. Through Voyage Manager's
Voyage Manager Links In
Travellers can now automatically update their LinkedIn profile with their latest Voyage Manager travel status updates. Voyage Manager has made another significant step in the world of social media with the integration of the VM Travel Tracking Suite with the world’s largest professional network, LinkedIn. The LinkedIn integration can automatically post travellers’ travel status updates, allowing colleagues and contacts to easily follow the progress of their trips. Through automation travellers
Device Manager Added To Voyage Manager Arsenal
(Cambridge, 9 September 2011) Voyage Manager has just added a new independent device tracking application to its already comprehensive list of features making it the most complete and all-encompassing Travel Management solution on the market. In addition to the organisational, monetary, and safety benefits that Voyage Manager already provides, the new device tracking application has made the system even more automated and user friendly. Incorporating HLR Lookup, Device Manager
CRFS appoints General Manager
Cambridge Company strengthens management team to support major growth CRFS, the Cambridge-based developer and manufacturer of innovative real-time spectral monitoring and signal analysis systems, has appointed Nick Balon as General Manager. He was previously Chief Operating Office at Xennia which he helped propel into a leading industrial inkjet company and which was acquired by TenCate Plc. He has been also been an active angel investor and mentor on
SaferWatch™ announces TIN Manager™
HEBRON, ND – SaferWatch announces the release of their latest software solution, TIN Manager™. The TIN Manager feature is designed to verify the accuracy of Taxpayer Identification Number (TIN) and name information prior to submitting 1099’s to the IRS so that the company will not be penalized or fined for mismatches. TIN Manager eliminates tax preparation hassles by giving the bookkeeping departments of broker and shipper businesses a